Bio-Techne Corp (TECH) Q3 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for your continued patience. Your meeting will begin shortly. If you need assistance at any time, please press star zero, and a member of our team will be happy to help you. ¶¶ ¶¶ 🎵 🎵 ¶¶ ¶¶ ¦ ¦ ¦ ¶¶ Thank you for your continued patience. Your meeting will begin shortly. If you need assistance at any time, please press star zero and a member of our team will be happy to help you. Thank you. © transcript Emily Beynon © transcript Emily Beynon Thank you for your continued patience. Your meeting will begin shortly. If you need assistance at any time, please press star zero and a member of our team will be happy to help you. Music ¶¶ Good morning and welcome to the Biotechni earnings conference call for the third quarter in fiscal year 2026. At this time, all participants have been placed in a listen-only mode, and the call will be open for questions following management's prepared remarks. During our Q&A session, please limit yourself to one question and one follow-up. I would now like to turn the call over to David Clare, Biotechnics Vice President, Investor Relations. Please go ahead. Good morning, and thank you for joining us. On the call with me this morning are Kim Kalderman, President and Chief Executive Officer of and Jim Hippel, Chief Financial Officer of Biotechni. Before we begin, let me briefly cover our safe harbor statement. Some of the comments made during this conference call may be considered forward-looking statements, including beliefs and expectations about the company's future results. The company's 10-K for fiscal 2025 identifies certain factors that could cause the company's actual results, to differ materially from those projected in the forward-looking statements made during this call. The company does not undertake to update any forwa...